Annals of Oncology10.1093/annonc/mdx670.002201728x123EGFR mutation is associated with short progression free survival in patients with stage IIIB non-squamous cell lung cancer treated with concurrent chemoradiotherapyS.E. Park, H. Lee, J.H. Cho, Y.J. Kim, H.K. Kim, S. Lim, S-H Lee, J-M Sun, J.S. Ahn, K. Park, M-J Ahn,,
Cancer Research and Treatment10.4143/crt.2018.1252019512493-501EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent ChemoradiotherapySong Ee Park, Jae Myoung Noh, You Jin Kim, Han Sang Lee, Jang Ho Cho, Sung Won Lim, Yong Chan Ahn, Hongryull Pyo, Yoon-La Choi, Joungho Han, Jong-Mu Sun, Se Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn,,
Lung Cancer10.1016/0169-5002(94)94461-x199411178Longterm survival results for patients with locally advanced non-small cell lung carcinoma (NSCLC) treated with aggressive concurrent chemoradiotherapy. (CT/TRT),
Lung Cancer10.1016/0169-5002(95)90721-11995132229Concurrent chemoradiotherapy followed by surgery for advanced stage III non-small cell lung cancer (NSCLC),
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2011.06.2742011812S133EGFR Mutation Status Predict Survival and Response for Patients with Stage III Squamous-cell Carcinoma of Lung Treated with ChemoradiotherapyG. Zhu, F. Li, H. Bai, X. Li, R. Yu, A. Shi, L. Yin, J. Wang,
Annals of Oncology10.1093/annonc/mdv049.08201526i24Omission of Elective Nodal Irradiation Has No Impact on Isolated Elective Nodal Failure and Survival Outcomes in Stage Iii Non-Small-Cell Lung Cancer Patients Treated with Definitive Concurrent ChemoradiotherapyE. Topkan, O.C. Guler, B.A. Yildirim,,
Current Problems in Cancer10.1016/j.currproblcancer.2018.04.002201943133-42Comparison of seventh TNM and eighth TNM staging system in stage III non–small cell lung cancer patients treated with concurrent chemoradiotherapyUfuk Yılmaz, Özer Özdemir, Ülkü Yılmaz,
Lung Cancer10.1016/s0169-5002(96)80074-21996153397Preoperative concurrent chemoradiotherapy for unresectable stage III nonsmall cell lung cancer,
10.21203/ Metformin Use and Survival Among Finnish Non-Small Cell Lung Cancer Patients Treated With EGFR TKIsSatu Tiainen, Sanna Iivanainen, Virve Alanen, Martti Arffman, Jussi P. Koivunen,
Lung Cancer10.1016/s0169-5002(18)30174-02018115S63-S64Service evaluation of stage III non-small cell lung cancer concurrent chemoradiotherapy treatment at Royal Cornwall Hospital Trust, TruroF. Mark,